Status:

COMPLETED

Determination of Walking, Balance, Fall Risk and Kinesiophobia in Individulas with Alzheimer's Dementation

Lead Sponsor:

Kırıkkale University

Conditions:

Alzheimer Disease

Eligibility:

All Genders

50-80 years

Brief Summary

THE OBJECTIVE OF THE RESEARCHERS IS TO DETERMINE WALKING, BALANCE, FALL RISK AND KINESIOPHOBIA IN INDIVIDUALS WITH ALZHEIMER'S DEMENTATION.

Detailed Description

The gait, balance, fall risks and kinesiophobia of individuals with Alzheimer's Dementia will be evaluated and compared with healthy individuals.

Eligibility Criteria

Inclusion

  • INDEPENDENT walker diagnosed with Alzheimer's Dementia

Exclusion

  • Having a disability to do physical activity Those who have had an operation in the last 6 months

Key Trial Info

Start Date :

March 1 2022

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

November 1 2022

Estimated Enrollment :

41 Patients enrolled

Trial Details

Trial ID

NCT05201768

Start Date

March 1 2022

End Date

November 1 2022

Last Update

December 3 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Kırıkkale University

Kırıkkale, Turkey (Türkiye)